NO312494B1 - Anvendelse av en tolags lipid/polar-lösningsmiddelblanding, farmasöytisk blanding som omfatter tolagslipid/polarlösningsmiddelblanding, samt fremgangsmåte forfremstilling av en sådan - Google Patents

Anvendelse av en tolags lipid/polar-lösningsmiddelblanding, farmasöytisk blanding som omfatter tolagslipid/polarlösningsmiddelblanding, samt fremgangsmåte forfremstilling av en sådan Download PDF

Info

Publication number
NO312494B1
NO312494B1 NO19963241A NO963241A NO312494B1 NO 312494 B1 NO312494 B1 NO 312494B1 NO 19963241 A NO19963241 A NO 19963241A NO 963241 A NO963241 A NO 963241A NO 312494 B1 NO312494 B1 NO 312494B1
Authority
NO
Norway
Prior art keywords
galactolipid
polar solvent
weight
mixture
bilayer
Prior art date
Application number
NO19963241A
Other languages
English (en)
Norwegian (no)
Other versions
NO963241L (no
NO963241D0 (no
Inventor
Anders Carlsson
Bengt Hersloef
Snezana Petrovic-Kaellholm
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9400368A external-priority patent/SE9400368D0/xx
Priority claimed from SE9402455A external-priority patent/SE9402455L/xx
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Publication of NO963241L publication Critical patent/NO963241L/no
Publication of NO963241D0 publication Critical patent/NO963241D0/no
Publication of NO312494B1 publication Critical patent/NO312494B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/005—Edible oil or fat compositions containing an aqueous phase, e.g. margarines characterised by ingredients other than fatty acid triglycerides
    • A23D7/0053—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L35/00—Foods or foodstuffs not provided for in groups A23L5/00 - A23L33/00; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetic Heads (AREA)
  • Coils Or Transformers For Communication (AREA)
  • Organic Insulating Materials (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
NO19963241A 1994-02-04 1996-08-02 Anvendelse av en tolags lipid/polar-lösningsmiddelblanding, farmasöytisk blanding som omfatter tolagslipid/polarlösningsmiddelblanding, samt fremgangsmåte forfremstilling av en sådan NO312494B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9400368A SE9400368D0 (sv) 1994-02-04 1994-02-04 Glycolipid material
SE9402455A SE9402455L (sv) 1994-07-12 1994-07-12 Biskiktspreparat
PCT/SE1995/000116 WO1995020944A1 (fr) 1994-02-04 1995-02-06 Preparations a deux couches

Publications (3)

Publication Number Publication Date
NO963241L NO963241L (no) 1996-08-02
NO963241D0 NO963241D0 (no) 1996-08-02
NO312494B1 true NO312494B1 (no) 2002-05-21

Family

ID=26661955

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963241A NO312494B1 (no) 1994-02-04 1996-08-02 Anvendelse av en tolags lipid/polar-lösningsmiddelblanding, farmasöytisk blanding som omfatter tolagslipid/polarlösningsmiddelblanding, samt fremgangsmåte forfremstilling av en sådan

Country Status (19)

Country Link
US (1) US6022561A (fr)
EP (1) EP0744939B1 (fr)
JP (1) JP3203358B2 (fr)
CN (1) CN1083713C (fr)
AT (1) ATE224704T1 (fr)
AU (1) AU691249B2 (fr)
CA (1) CA2182576C (fr)
DE (1) DE69528355T2 (fr)
DK (1) DK0744939T3 (fr)
ES (1) ES2183865T3 (fr)
FI (1) FI963065L (fr)
HU (1) HUT75459A (fr)
MY (1) MY113341A (fr)
NO (1) NO312494B1 (fr)
NZ (1) NZ279953A (fr)
PL (1) PL178438B1 (fr)
PT (1) PT744939E (fr)
TW (1) TW402502B (fr)
WO (1) WO1995020944A1 (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504664C2 (sv) * 1995-09-22 1997-03-24 Scotia Lipidteknik Ab Sätt att framställa fraktionerad olja, oljan, dess användning samt emulsionskomposition innehållande oljan
ATE348518T1 (de) 1996-10-25 2007-01-15 Monsanto Technology Llc Zusammensetzung und verfahren zur behandlung von pflanzen mit exogenen chemikalien
HUP9904006A3 (en) * 1996-10-25 2002-01-28 Monsanto Technology Llc St Louis Composition and method for treating plants with exogenous chemicals
AU727026B2 (en) * 1996-11-08 2000-11-30 Takara Bio Inc. Apoptosis inducing agent
PL333331A1 (en) * 1997-09-09 1999-12-06 Select Release Coated particles, method of producing them and their application
EP1043016B1 (fr) 1999-03-30 2014-08-20 Sodic Sa Extrait de plante à base de glycérides, phospholipides et phytosphingolipides, son procédé de préparation et compositions cosmétiques le renfermant
FR2810540B1 (fr) * 2000-06-21 2004-04-30 C3D Nouvelles preparations cosmetiques ou hygieniques sous forme de dispersion
FR2814071A1 (fr) * 2000-09-21 2002-03-22 Oreal Composition a base de glycoglyceride et ses utilisations notamment cosmetiques
US6890255B2 (en) 2001-12-17 2005-05-10 Igt Multiple wheel roulette game
DK1499294T3 (da) * 2002-04-29 2010-12-06 Biotesys Gmbh Polymeriserede, peptid-modificerede lipider som biologiske transportsystemer til mikronæringsstoffer
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
SE0300207D0 (sv) 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition
DE10336841A1 (de) * 2003-08-11 2005-03-17 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetische Zusammensetzung zur Unterstützung des Sauerstofftransports in die Haut
SE0401942D0 (sv) * 2004-07-28 2004-07-28 Lipopeptide Ab New antimicrobial peptide complexes
CA2928387A1 (fr) 2004-05-03 2005-11-17 Merrimack Pharmaceuticals, Inc. Liposomes pour l'administration de drogues contenant des polyols anioniques ou des sucres anioniques
US8658203B2 (en) * 2004-05-03 2014-02-25 Merrimack Pharmaceuticals, Inc. Liposomes useful for drug delivery to the brain
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
WO2006067402A2 (fr) 2004-12-22 2006-06-29 Lipopeptide Ab Nouveaux agents et leur utilisation
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (fr) 2005-02-03 2006-08-10 Alza Corporation Solutions de solvant/polymere utilisees comme vehicules de suspension
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
DE102006015544A1 (de) * 2006-03-31 2007-10-04 Kuhs Gmbh Topisch zu applizierende Zusammensetzung
MX2008014870A (es) 2006-05-30 2009-02-12 Intarcia Therapeutics Inc Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP2049081B1 (fr) 2006-08-09 2012-11-14 Intarcia Therapeutics, Inc. Systemes d'administration osmotiques et ensembles pistons
WO2008084253A1 (fr) * 2007-01-12 2008-07-17 Lipopeptide Ab Utilisation d'un galactolipide pour cicatrisation de plaies et d'ulcères
HRP20130259T1 (hr) 2007-04-23 2013-04-30 Intarcia Therapeutics, Inc. Suspenzijske formulacije inzulinotropnih peptida i njihove uporabe
US20090137497A1 (en) * 2007-11-23 2009-05-28 Beiersdorf Ag Active ingredient combinations of glucosyl glycerides and creatine and/or creatinine
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
WO2009131672A1 (fr) * 2008-04-22 2009-10-29 University Of Massachusetts Compositions de liposomes stabilisées et procédés d’utilisation associés
CA2754707C (fr) * 2009-03-11 2016-11-22 Swedish Oat Fiber Ab Procede de separation de lipides neutres et polaires et d'une huile riche en lipides polaires
SMT201700583T1 (it) 2009-09-28 2018-01-11 Intarcia Therapeutics Inc Instaurazione e/o terminazione rapida di erogazione di farmaci in modo sostanzialmente stazionario
WO2011043008A1 (fr) * 2009-10-07 2011-04-14 パナソニック株式会社 Procédé pour former une membrane lipidique artificielle
UA111147C2 (uk) 2009-11-11 2016-04-11 Байєр Б.В. Способи та композиції для лікування або профілактики зовнішнього отиту
WO2011087403A1 (fr) * 2010-01-18 2011-07-21 Lipidor Ab Alcoolyse de glycolipide et produit de lyse correspondant
ES2662710T3 (es) 2010-05-24 2018-04-09 Swedish Oat Fiber Ab Dispersión acuosa que comprende galactolípidos y método de producción de la misma
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
CA2830298C (fr) 2011-03-17 2016-08-16 Transdermal Biotechnology, Inc. Produits d'oxyde nitrique topiques comprenant de la lecithine et leurs methodes d'utilisation
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en) 2015-06-03 2021-02-23 Intarcia Therapeutics, Inc. Implant placement and removal systems
MX382522B (es) 2015-10-16 2025-03-13 Ipsen Biopharm Ltd Composiciones farmaceuticas estabilizantes de camptotecina.
RU2760007C2 (ru) 2016-05-16 2021-11-22 Интарсия Терапьютикс, Инк. Полипептиды, селективные к рецепторам глюкагона, и способы их применения
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
CN110225762A (zh) 2017-01-03 2019-09-10 因塔西亚制药公司 包括glp-1受体激动剂的连续施用和药物的共同施用的方法
CN110183500B (zh) * 2019-07-05 2022-09-09 湖北中医药大学 一种植物半乳糖脂的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US437567A (en) * 1890-09-30 Cash and parcel carrier
EP0009842B1 (fr) * 1978-10-02 1982-11-10 THE PROCTER & GAMBLE COMPANY Liposomes pour la libération d'agents pharmaceutiques et composition contenant un système d'agent pharmaceutique à liposome
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
CA1320130C (fr) * 1986-06-12 1993-07-13 Alan L. Weiner Methodes et compositions faisant appel a des antiinflammatoires non steroidiens encapsules dans des liposomes
US5234767A (en) * 1987-03-13 1993-08-10 Micro-Pak, Inc. Hybrid paucilamellar lipid vesicles
DK0384798T3 (da) * 1989-02-06 1993-12-06 Soma Genichiro Limulustest-positivt planteglycolipid samt fremgangsmåde til stimulering af et dyrs immunsystem

Also Published As

Publication number Publication date
FI963065A0 (fi) 1996-08-02
ES2183865T3 (es) 2003-04-01
PL315779A1 (en) 1996-12-09
TW402502B (en) 2000-08-21
DE69528355T2 (de) 2003-05-15
NZ279953A (en) 1998-02-26
PT744939E (pt) 2003-02-28
NO963241L (no) 1996-08-02
PL178438B1 (pl) 2000-04-28
AU1723495A (en) 1995-08-21
FI963065A7 (fi) 1996-09-30
WO1995020944A1 (fr) 1995-08-10
EP0744939A1 (fr) 1996-12-04
ATE224704T1 (de) 2002-10-15
EP0744939B1 (fr) 2002-09-25
HUT75459A (en) 1997-05-28
JPH09508414A (ja) 1997-08-26
AU691249B2 (en) 1998-05-14
CN1083713C (zh) 2002-05-01
DK0744939T3 (da) 2003-02-03
JP3203358B2 (ja) 2001-08-27
CA2182576C (fr) 2002-09-17
FI963065L (fi) 1996-09-30
HU9602146D0 (en) 1996-09-30
US6022561A (en) 2000-02-08
CA2182576A1 (fr) 1995-08-10
CN1144478A (zh) 1997-03-05
NO963241D0 (no) 1996-08-02
DE69528355D1 (de) 2002-10-31
MY113341A (en) 2002-01-31

Similar Documents

Publication Publication Date Title
AU691249B2 (en) Bilayer preparations
US5716639A (en) Lipophilic carrier preparations
AU691248B2 (en) Oil-in-water emulsions
EP1011634B1 (fr) Preparation de compositions pharmaceutiques
EP0514506B1 (fr) Systeme de formulation de lipides
US9622970B2 (en) Pharmaceutical composition containing lutein and antioxidant for treating and preventing human disease
RU2166332C2 (ru) Двуслойные препараты
RU2131266C1 (ru) Эмульсия типа "масло в воде", носитель на ее основе и фармацевтическая композиция
JP3287941B2 (ja) 安定なリポソームの水分散液
MXPA96003038A (en) Oil emulsions in a
CN115737565A (zh) 一种五味子乙素脂质体及其制备方法

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees